Home Featured Page 138

Featured

Latest

Pα+ Psychedelic Bulletin #214: LSD Microdosing Program Collapses; AtaiBeckley’s Phase 2b Debrief; UK Government Responds to MPs’ Psilocybin-Related Questions

Dr Jason Konner – Psychedelic Oncology and the Future of Cancer Care

The Psychedelic News Feed: November 3 – 9, 2025

The Psychedelic News Feed: November 10 – 16, 2025

Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action

Numinus to Participate in a Water Tower Research Fireside Chat on...

Reunion Neuroscience Inc. Announces Executive Changes

PT362 – Cory Firth – Psychedelic Storytelling: Transforming Out Loud

Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health

Silo Pharma to Present at the Dawson James Small Cap Growth...

COMPASS Pathways to Hold Virtual Capital Market Day on 12 October...

MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference

Numinus Develops Mushroom Tea for Use in Psychedelic Research

Mindset Pharma Selects Lead Clinical Candidates From “Family 2” of its...

PharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson’s...

1...137138139...302 Page 138 of 302

Pα+ Psychedelic Bulletin #214: LSD Microdosing Program Collapses; AtaiBeckley’s Phase 2b...

Dr Jason Konner – Psychedelic Oncology and the Future of Cancer...

The Psychedelic News Feed: November 3 – 9, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Pα+ Psychedelic Bulletin #214: LSD Microdosing Program Collapses; AtaiBeckley’s Phase 2b Debrief; UK Government Responds to MPs’ Psilocybin-Related Questions

Dr Jason Konner – Psychedelic Oncology and the Future of Cancer Care

The Psychedelic News Feed: November 3 – 9, 2025

The Psychedelic News Feed: November 10 – 16, 2025

Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action

Numinus to Participate in a Water Tower Research Fireside Chat on...

Reunion Neuroscience Inc. Announces Executive Changes

PT362 – Cory Firth – Psychedelic Storytelling: Transforming Out Loud

Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health

Silo Pharma to Present at the Dawson James Small Cap Growth...

COMPASS Pathways to Hold Virtual Capital Market Day on 12 October...

MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference

Numinus Develops Mushroom Tea for Use in Psychedelic Research

Mindset Pharma Selects Lead Clinical Candidates From “Family 2” of its...

PharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson’s...

EDITOR PICKS

Pα+ Psychedelic Bulletin #214: LSD Microdosing Program Collapses; AtaiBeckley’s Phase 2b...

Dr Jason Konner – Psychedelic Oncology and the Future of Cancer...

The Psychedelic News Feed: November 3 – 9, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY